-
1
-
-
0030897009
-
International scoring system for evaluating prognosis in myelodysplastic syndromes
-
Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997;89:2079-88.
-
(1997)
Blood
, vol.89
, pp. 2079-2088
-
-
Greenberg, P.1
Cox, C.2
LeBeau, M.M.3
-
2
-
-
54349092877
-
Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype
-
Breems DA, Van Putten WL, De Greef GE, et al. Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype. J Clin Oncol 2008;26:4791-7.
-
(2008)
J Clin Oncol
, vol.26
, pp. 4791-4797
-
-
Breems, D.A.1
Van Putten, W.L.2
De Greef, G.E.3
-
3
-
-
84155167315
-
Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activity
-
Ahn HK, Jang JH, Kim K, Kim HJ, Kim SH, Jung CW, Kim DH. Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activity. Am J Hematol 2012;87:37-41.
-
(2012)
Am J Hematol
, vol.87
, pp. 37-41
-
-
Ahn, H.K.1
Jang, J.H.2
Kim, K.3
Kim, H.J.4
Kim, S.H.5
Jung, C.W.6
Kim, D.H.7
-
4
-
-
80051609304
-
Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation
-
Fang M, Storer B, Estey E, Othus M, Zhang L, Sandmaier BM, Appelbaum FR. Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation. Blood 2011;118:1490-4.
-
(2011)
Blood
, vol.118
, pp. 1490-1494
-
-
Fang, M.1
Storer, B.2
Estey, E.3
Othus, M.4
Zhang, L.5
Sandmaier, B.M.6
Appelbaum, F.R.7
-
5
-
-
79551681707
-
Monosomal karyotype provides better prognostic prediction after allogeneic stem cell transplantation in patients with acute myelogenous leukemia
-
Oran B, Dolan M, Cao Q, Brunstein C, Warlick E, Weisdorf D. Monosomal karyotype provides better prognostic prediction after allogeneic stem cell transplantation in patients with acute myelogenous leukemia. Biol Blood Marrow Transplant 2011;17:356-64.
-
(2011)
Biol Blood Marrow Transplant
, vol.17
, pp. 356-364
-
-
Oran, B.1
Dolan, M.2
Cao, Q.3
Brunstein, C.4
Warlick, E.5
Weisdorf, D.6
-
6
-
-
79960661181
-
Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities
-
Perrot A, Luquet I, Pigneux A, et al. Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities. Blood 2011;118:679-85.
-
(2011)
Blood
, vol.118
, pp. 679-685
-
-
Perrot, A.1
Luquet, I.2
Pigneux, A.3
-
7
-
-
79959959049
-
Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial
-
Stelljes M, Beelen DW, Braess J, et al. Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial. Haematologica 2011;96:972-9.
-
(2011)
Haematologica
, vol.96
, pp. 972-979
-
-
Stelljes, M.1
Beelen, D.W.2
Braess, J.3
-
8
-
-
84855857727
-
Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies
-
Kayser S, Zucknick M, Dohner K, et al. Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies. Blood 2012;119:551-8.
-
(2012)
Blood
, vol.119
, pp. 551-558
-
-
Kayser, S.1
Zucknick, M.2
Dohner, K.3
-
9
-
-
84857734093
-
TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome
-
Rucker FG, Schlenk RF, Bullinger L, et al. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome. Blood 2012;119:2114-21.
-
(2012)
Blood
, vol.119
, pp. 2114-2121
-
-
Rucker, F.G.1
Schlenk, R.F.2
Bullinger, L.3
-
10
-
-
79953047317
-
Autosomal monosomies among 24,262 consecutive cytogenetic studies: prevalence, chromosomal distribution and clinicopathologic correlates of sole abnormalities
-
Raza S, TaherNazerHussain F, Patnaik M, Knudson R, Van Dyke D, Tefferi A. Autosomal monosomies among 24, 262 consecutive cytogenetic studies: prevalence, chromosomal distribution and clinicopathologic correlates of sole abnormalities. Am J Hematol 2011;86:353-6.
-
(2011)
Am J Hematol
, vol.86
, pp. 353-356
-
-
Raza, S.1
TaherNazerHussain, F.2
Patnaik, M.3
Knudson, R.4
Van Dyke, D.5
Tefferi, A.6
-
11
-
-
79751531643
-
Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype
-
Patnaik MM, Hanson CA, Hodnefield JM, Knudson R, Van Dyke DL, Tefferi A. Monosomal karyotype in myelodysplastic syndromes, with or without monosomy 7 or 5, is prognostically worse than an otherwise complex karyotype. Leukemia 2011;25:266-70.
-
(2011)
Leukemia
, vol.25
, pp. 266-270
-
-
Patnaik, M.M.1
Hanson, C.A.2
Hodnefield, J.M.3
Knudson, R.4
Van Dyke, D.L.5
Tefferi, A.6
-
12
-
-
84866355881
-
-
Cancer Therapy Evaluation Program. Common terminology criteria for adverse events, version 3.0, DCTD, NCI, NIH, DHHS, 2003. Available from:
-
Cancer Therapy Evaluation Program. Common terminology criteria for adverse events, version 3.0, DCTD, NCI, NIH, DHHS, 2003. Available from: http://ctep.cancer.gov.
-
-
-
-
13
-
-
77957715843
-
Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience
-
Medeiros BC, Othus M, Fang M, Roulston D, Appelbaum FR. Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience. Blood 2010;116:2224-8.
-
(2010)
Blood
, vol.116
, pp. 2224-2228
-
-
Medeiros, B.C.1
Othus, M.2
Fang, M.3
Roulston, D.4
Appelbaum, F.R.5
-
14
-
-
79959358531
-
Partial and total monosomal karyotypes in myelodysplastic syndromes: comparative prognostic relevance among 421 patients
-
Belli CB, Bengio R, Aranguren PN, Sakamoto F, Flores MG, Watman N, Nucifora E, Prates MV, Arbelbide J, Larripa I. Partial and total monosomal karyotypes in myelodysplastic syndromes: comparative prognostic relevance among 421 patients. Am J Hematol 2011;86:540-5.
-
(2011)
Am J Hematol
, vol.86
, pp. 540-545
-
-
Belli, C.B.1
Bengio, R.2
Aranguren, P.N.3
Sakamoto, F.4
Flores, M.G.5
Watman, N.6
Nucifora, E.7
Prates, M.V.8
Arbelbide, J.9
Larripa, I.10
-
15
-
-
84865160517
-
Prognostic impact of monosomal karyotype in patients with myelodysplastic syndrome and abnormal karyotype. A Report From the Spanish Group of MDS (GESMD) [Abstract]
-
ASH Annual Meeting Abstracts) ;:Abstract 1724.
-
Valcárcel D, Adema V, Mallo M, et al. Prognostic impact of monosomal karyotype in patients with myelodysplastic syndrome and abnormal karyotype. A Report From the Spanish Group of MDS (GESMD) [Abstract]. Blood (ASH Annual Meeting Abstracts) 2011;118:Abstract 1724.
-
(2011)
Blood
, vol.118
-
-
Valcárcel, D.1
Adema, V.2
Mallo, M.3
-
16
-
-
79960207573
-
Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine
-
Itzykson R, Thepot S, Eclache V, et al. Prognostic significance of monosomal karyotype in higher risk myelodysplastic syndrome treated with azacitidine. Leukemia 2011;25:1207-9.
-
(2011)
Leukemia
, vol.25
, pp. 1207-1209
-
-
Itzykson, R.1
Thepot, S.2
Eclache, V.3
-
17
-
-
85018256550
-
Monosomal karyotype in myeloid malignancies is prognostically worse even after allogeneic hematopoietc stem cell transplantaion; results from two transplant centers [Abstract]
-
ASH Annual Meeting Abstracts) ;:Abstract 4154.
-
Koichiro M, Shigematsu A, Nakata M, et al. Monosomal karyotype in myeloid malignancies is prognostically worse even after allogeneic hematopoietc stem cell transplantaion; results from two transplant centers [Abstract]. Blood (ASH Annual Meeting Abstracts) 2011;118:Abstract 4154.
-
(2011)
Blood
, vol.118
-
-
Koichiro, M.1
Shigematsu, A.2
Nakata, M.3
-
18
-
-
84876106217
-
Complex karyotype predicts outcome better than monosomal karyotype in patients with mds/secondary acute leukemia treated with allogeneic hematopoietic stem cell transplantation (HSCT): a Retrospective Survey on Behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) [Abstract]
-
ASH Annual Meeting Abstracts) ;:Abstract 578.
-
Brands-Nijenhuis A, Van Gelder M, De Witte T, Schetelig J, Van Biezen A, Kroeger N. Complex karyotype predicts outcome better than monosomal karyotype in patients with mds/secondary acute leukemia treated with allogeneic hematopoietic stem cell transplantation (HSCT): a Retrospective Survey on Behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) [Abstract]. Blood (ASH Annual Meeting Abstracts) 2010;116:Abstract 578.
-
(2010)
Blood
, vol.116
-
-
Brands-Nijenhuis, A.1
Van Gelder, M.2
De Witte, T.3
Schetelig, J.4
Van Biezen, A.5
Kroeger, N.6
-
19
-
-
33745121881
-
Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide
-
Hallemeier CL, Girgis MD, Blum WG, Brown RA, Khoury HJ, Devine SM, Vij R, Lin HS, DiPersio JF, Adkins DR. Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide. Biol Blood Marrow Transplant 2006;12:749-57.
-
(2006)
Biol Blood Marrow Transplant
, vol.12
, pp. 749-757
-
-
Hallemeier, C.L.1
Girgis, M.D.2
Blum, W.G.3
Brown, R.A.4
Khoury, H.J.5
Devine, S.M.6
Vij, R.7
Lin, H.S.8
DiPersio, J.F.9
Adkins, D.R.10
-
20
-
-
35648955094
-
Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome
-
Nakamura R, Rodriguez R, Palmer J, et al. Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome. Bone Marrow Transplant 2007;40:843-50.
-
(2007)
Bone Marrow Transplant
, vol.40
, pp. 843-850
-
-
Nakamura, R.1
Rodriguez, R.2
Palmer, J.3
-
21
-
-
83655184694
-
Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome
-
Buchholz S, Dammann E, Stadler M, Krauter J, Beutel G, Trummer A, Eder M, Ganser A. Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome. Eur J Haematol 2012;88:52-60.
-
(2012)
Eur J Haematol
, vol.88
, pp. 52-60
-
-
Buchholz, S.1
Dammann, E.2
Stadler, M.3
Krauter, J.4
Beutel, G.5
Trummer, A.6
Eder, M.7
Ganser, A.8
-
22
-
-
80053176430
-
Hematopoietic stem cell transplantation for myelodysplastic syndrome: a review
-
Parmar S, de Lima M, Deeg HJ, Champlin R. Hematopoietic stem cell transplantation for myelodysplastic syndrome: a review. Semin Oncol 2011;38:693-704.
-
(2011)
Semin Oncol
, vol.38
, pp. 693-704
-
-
Parmar, S.1
de Lima, M.2
Deeg, H.J.3
Champlin, R.4
-
23
-
-
80052576601
-
Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life
-
Alatrash G, de Lima M, Hamerschlak N, et al. Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life. Biol Blood Marrow Transplant 2011;17:1490-6.
-
(2011)
Biol Blood Marrow Transplant
, vol.17
, pp. 1490-1496
-
-
Alatrash, G.1
de Lima, M.2
Hamerschlak, N.3
-
24
-
-
58149196171
-
Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden
-
Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Biol Blood Marrow Transplant 2009;15:30-8.
-
(2009)
Biol Blood Marrow Transplant
, vol.15
, pp. 30-38
-
-
Warlick, E.D.1
Cioc, A.2
Defor, T.3
Dolan, M.4
Weisdorf, D.5
-
25
-
-
84866395442
-
The novel 5-group cytogenetic risk classification of myelodysplastic syndrome (MDS), monosomal karyotype, and outcome after allogeneic hematopoietic cell transplantation (HCT) [Abstract]
-
Abstract 212.
-
Gerds A, Gooley T, Scott BL, Appelbaum FR, Deeg HJ. The novel 5-group cytogenetic risk classification of myelodysplastic syndrome (MDS), monosomal karyotype, and outcome after allogeneic hematopoietic cell transplantation (HCT) [Abstract]. Biol Blood Marrow Transplant 2012;18:Abstract 212.
-
(2012)
Biol Blood Marrow Transplant
, vol.18
-
-
Gerds, A.1
Gooley, T.2
Scott, B.L.3
Appelbaum, F.R.4
Deeg, H.J.5
-
26
-
-
79952079761
-
Monosomal karyotype predicts poor outcome for MDS/sAML patients with chromosome 7 abnormalities after allogeneic stem cell transplantation for MDS/sAML: a study of the MDS Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) [Abstract]
-
ASH Annual Meeting Abstracts) ;:Abstract 293.
-
Van Gelder M, Schetelig J, Volin L. Monosomal karyotype predicts poor outcome for MDS/sAML patients with chromosome 7 abnormalities after allogeneic stem cell transplantation for MDS/sAML: a study of the MDS Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT) [Abstract]. Blood (ASH Annual Meeting Abstracts) 2009;114:Abstract 293.
-
(2009)
Blood
, vol.114
-
-
Van Gelder, M.1
Schetelig, J.2
Volin, L.3
|